News

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
People on weight-loss drugs often lose muscle mass while they lose weight, but new scientific findings suggest boosting your ...
The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.
Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...
People are injecting peptides to build muscle, trim fat, and reduce inflammation. Does it work?